These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 27067488)
1. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia. Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488 [TBL] [Abstract][Full Text] [Related]
2. Erythroferrone contributes to recovery from anemia of inflammation. Kautz L; Jung G; Nemeth E; Ganz T Blood; 2014 Oct; 124(16):2569-74. PubMed ID: 25193872 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly. Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735 [TBL] [Abstract][Full Text] [Related]
4. Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice. Wang CY; Core AB; Canali S; Zumbrennen-Bullough KB; Ozer S; Umans L; Zwijsen A; Babitt JL Blood; 2017 Jul; 130(1):73-83. PubMed ID: 28438754 [TBL] [Abstract][Full Text] [Related]
5. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Vokurka M; Krijt J; Sulc K; Necas E Physiol Res; 2006; 55(6):667-674. PubMed ID: 16497104 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia. Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietic regulators of iron metabolism. Ganz T Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834 [TBL] [Abstract][Full Text] [Related]
8. Effect of Erythropoietin on the Expression of Murine Transferrin Receptor 2. Berezovsky B; Báječný M; Frýdlová J; Gurieva I; Rogalsky DW; Přikryl P; Pospíšil V; Nečas E; Vokurka M; Krijt J Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360974 [TBL] [Abstract][Full Text] [Related]
9. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665 [TBL] [Abstract][Full Text] [Related]
10. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707 [TBL] [Abstract][Full Text] [Related]
11. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant. Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730 [TBL] [Abstract][Full Text] [Related]
12. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia. Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO J Nutr; 2021 Jul; 151(7):1824-1833. PubMed ID: 33982118 [TBL] [Abstract][Full Text] [Related]
14. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study. Zaman BA; Rasool SO; Abdo JM Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905 [TBL] [Abstract][Full Text] [Related]
15. Erythroferrone inhibits the induction of hepcidin by BMP6. Arezes J; Foy N; McHugh K; Sawant A; Quinkert D; Terraube V; Brinth A; Tam M; LaVallie ER; Taylor S; Armitage AE; Pasricha SR; Cunningham O; Lambert M; Draper SJ; Jasuja R; Drakesmith H Blood; 2018 Oct; 132(14):1473-1477. PubMed ID: 30097509 [TBL] [Abstract][Full Text] [Related]
16. Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice. Coffey R; Sardo U; Kautz L; Gabayan V; Nemeth E; Ganz T Physiol Rep; 2018 Sep; 6(19):e13890. PubMed ID: 30315639 [TBL] [Abstract][Full Text] [Related]
17. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure. Robach P; Gammella E; Recalcati S; Girelli D; Castagna A; Roustit M; Lundby C; Lundby AK; Bouzat P; Vergès S; Séchaud G; Banco P; Uhr M; Cornu C; Sallet P; Cairo G Haematologica; 2021 Feb; 106(2):384-390. PubMed ID: 31919080 [TBL] [Abstract][Full Text] [Related]
18. Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor. Kralova B; Sochorcova L; Song J; Jahoda O; Hlusickova Kapralova K; Prchal JT; Divoky V; Horvathova M Am J Hematol; 2022 Oct; 97(10):1286-1299. PubMed ID: 35815815 [TBL] [Abstract][Full Text] [Related]
19. Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia. Latour C; Wlodarczyk MF; Jung G; Gineste A; Blanchard N; Ganz T; Roth MP; Coppin H; Kautz L Haematologica; 2017 Jan; 102(1):60-68. PubMed ID: 27658439 [TBL] [Abstract][Full Text] [Related]
20. Identification of erythroferrone as an erythroid regulator of iron metabolism. Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]